Page last updated: 2024-09-05

tak 779 and Disease Exacerbation

tak 779 has been researched along with Disease Exacerbation in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cambien, B; Ferrua, B; Karimdjee, BF; Martini, V; Pitard, B; Richard-Fiardo, P; Schmid-Alliana, A; Schmid-Antomarchi, H	1
Kadam, PA; Lawrence, DM; Peehl, DM; Vaday, GG	1

Other Studies

2 other study(ies) available for tak 779 and Disease Exacerbation

Article	Year
CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinoma. PloS one, 2011, Volume: 6, Issue:12 Topics: Amides; Animals; Antibodies, Neutralizing; Cell Movement; Cell Proliferation; Chemokine CCL5; CHO Cells; Colorectal Neoplasms; Cricetinae; Cricetulus; Disease Progression; Female; HT29 Cells; Humans; Leukocytes; Mice; Molecular Targeted Therapy; Neoplasm Metastasis; Quaternary Ammonium Compounds; Receptor, Platelet-Derived Growth Factor beta; Receptors, CCR5; Treatment Outcome	2011
Expression of CCL5 (RANTES) and CCR5 in prostate cancer. The Prostate, 2006, Feb-01, Volume: 66, Issue:2 Topics: Adenocarcinoma; Amides; Autocrine Communication; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Chemokine CCL5; Chemokines, CC; Disease Progression; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Quaternary Ammonium Compounds; Receptors, CCR5; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2006

Article

Year

CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinoma.

PloS one, 2011, Volume: 6, Issue:12

Topics: Amides; Animals; Antibodies, Neutralizing; Cell Movement; Cell Proliferation; Chemokine CCL5; CHO Cells; Colorectal Neoplasms; Cricetinae; Cricetulus; Disease Progression; Female; HT29 Cells; Humans; Leukocytes; Mice; Molecular Targeted Therapy; Neoplasm Metastasis; Quaternary Ammonium Compounds; Receptor, Platelet-Derived Growth Factor beta; Receptors, CCR5; Treatment Outcome

2011

Expression of CCL5 (RANTES) and CCR5 in prostate cancer.

The Prostate, 2006, Feb-01, Volume: 66, Issue:2

Topics: Adenocarcinoma; Amides; Autocrine Communication; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Chemokine CCL5; Chemokines, CC; Disease Progression; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Quaternary Ammonium Compounds; Receptors, CCR5; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2006